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Unexpected hypoxia-dependent erythropoietin secretion during exper-
imental conditions not affecting tissue oxygen supply/demand ratio.
Although a great deal of evidence supports the hypothesis that plasma
erythropoietin (EPO) levels of mammals are related to the oxygen supply
to the tissues relative to their oxygen needs, several observations millitate
against its inherent simplicity. This study presents our results obtained
from in vivo experiments that suggest that hypoxia-dependent EPO
production can be altered by conditions which apparently do not modify
the tissue oxygen supply/demand ratio. Hypoxia-dependent EPO produc-
tion rate (EPO-PR), derived from plasma EPO titers and plasma EPO
half-lives, were estimated in both transfused-polycythemic and normocy-
themic mouse models subjected to different treatments. From calculations
of the 02 carrying capacity of blood and body 02 consumption, it was
assumed that the tissue supply/demand ratios were similar in both
experimental and control mice of the same model at the time of induction
of EPO production. The following observations were worth noting: (1)
EPO-PRs in transfused polycythemic mice whose erythropoietic rates
were stimulated by intermittent exposure to hypobaria (0.5 atm, 18
hr/day x 3 weeks), phenylhydrazine administration (40 mg/kg at weekly
intervals X 3 weeks) or repeated rh-EPO injections (1500 U/kg 3 times a
week X 3 weeks) before transfusion were more than five times higher than
in comparabily polycythemic mice whose erythropoietic rates were not
stimulated previously; and (2) EPO-PR in response to hypobaric hypoxia
was 2.08 times normal in normocythemic mice with cyclophosphamide
(100 mg/kg) induced depression of erythropoiesis, and 0.33 times normal
in normocythemic mice with rh-EPO (400 U/kg >< 2) induced enhance-
ment of erythropoiesis. Although the results obtained in polycythemic
mice are difficult to explain, those from normocythemic mice suggest the
existence of a feedback mechanism between EPO-responsive cells and
EPO-producing cells. Both demonstrate the existence of experimental
conditions in which modulation of the hypoxia-dependent expression of
the EPO gene appears to occur. This modulation would be dependent on
factors other than oxygen.
Erythropoietin (EPO) is a 30.4 kDa glycoprotein that appears
to he the key regulator of red cell production [1]. It is mainly
synthesized by endocrine renal cells through the expression of an
EPO gene apparently in response to transcription-regulating
factors. Studies conducted on hepatoma cells have shown that one
of these factors appears to be constitutively expressed, which explain
the presence of immuno-EPO in the plasma of mice made severily
polycythemic by hypertransfusion [2]. Another transcription-regulat-
ing factor was named hypoxia-inducible factor 1 (HIF-1) [3]. It is only
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present in extracts from hypoxic cells and may be responsible for the
hypoxia-dependent expression of the EPO gene.
According to the old hypothesis of Fried et al [4], that EPO
synthesis depends on the convective oxygen supply to tissues
relative to their oxygen needs, it seems evident that the EPO
synthesis rate is negatively correlated to oxygen availability,
namely tissue P°2• A structure, possibly a hemoprotein, has thus
been proposed that senses the oxygen tension and initiates a signal
that turns on the expression of the EPO gene [5, 6].
Although Fried's hypothesis has received strong experimental
and clinical support, several studies [7—10] militate against its
inherent simplicity. The purpose of this communication is to
present results obtained from in vivo experiments that suggest that
the oxygen-dependent EPO production rate (EPO-PR) can be
altered by conditions which apparently do not modify the oxygen
supply/demand ratio.
Methods
Adult female CF1 mice were used throughOut. They were fed a
standard rodent chow and water ad libitum. Hypobaric hypoxemia
was induced by exposing mice to air maintained at 50% atmo-
spheric pressure in a simulated high altitude chamber. Recombi-
nant human EPO (rh-EPO) (Bio Sidus, Argentina; 400 to 1500
U/kg/dose), cyclophosphamide (Endoxan Asta, 100 mg/kg/dose)
or phenylhydrazine (20 to 40 mg/kg/dose) were injected to stint-
ulate or depress erythropoiesis or to induce a compensated
hemolytic state, respectively. Erythropoiesis was measured by the
percent of a tracer dose (0.2 j.tCi) of 59Fe incorporated into the
circulating red cell volume (24 hr). Plasma disappearance of
rh-EPO was determined by injecting 30 mice i.v. with 600,000 cpm
of '251-Iabeled hormone with subsequent bleeding of the animals
in groups of five every hour for six hours. The radioactivity in 100
1d of plasma was measured and plotted semilogarithmically versus
time. Plasma EPO (pEPO) levels were determined by radioim-
munoassay, as previously described [11]. The EPO-PR was calcu-
lated from pEPO values according to the equation
PR = (EPOf — EPO0 ekt)/(1 — eH) - K
where EPO0 and EPOf are the basal plasma level and the plasma
level at the end of the exposure to hypobaria, respectively. PR is the
production rate of the hormone (K = 1n2/EPO t112). Oxygen
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consumption was determined with an OXIMAX fuily computerized
system (Columbus Instruments, Columbus, OH, USA).
Results
Experiment 1. Hypoxia-dependent EPO production in the
transfitsed-polycythemic mice: Effect of previous stimulation of
eiythropoiesis
Erythropoiesis was stimulated during a three week period in
normal mice by induction of hypobaric hypoxcmia (18 hr/day), by
administration of phcnylhydrazine (initial dose of 40 mg/kg on the
first week, followed by doses of 20 mg/kg at weeky intervals), or by
injection of rh-EPO (1500 U/kg three times a week). Both control
mice with normal erythropoiesis and mice with enhanced eryth-
ropoiesis in response to the phenylhydrazine-induced hemolytic
state were made polycythemic by injecting them with packed red
cells on two consecutive days. The hematocrit was measured in all
mice of the remaining groups at the end of the period of
stimulation of erythropoiesis. When necessary, mice were trans-
fused in order to keep the hematocrit level around 0.65. It was
done so because the erythropoietic response of transfused-poly-
cythemic mice to acute hypoxemia was negatively related to the
degree of polycythemia [12]. Mice from each group were exposed
to hypobaria (14 hr) four days after the end of the period of
erythropoictic stimulation or after transfusion, depending on the
specific group. They were bled immediately after hypoxic stimu-
lation. Plasma rh-EPO t12 was also measured in all groups. The
value of 182.8 + 14.4 minutes found in normal mice was not
significantly modified by treatments. Figure 1 shows the EPO-PR
during hypoxemia derived from all experimental groups. Two
observations are worth noting: (1) EPO-PR was depressed in mice
with normal erythropoiesis after transfusion (NC vs. PC); and (2)
EPO-PRs in transfused polyeythemic mice whose erythropoiesis
were previously stimulated by intermittent hypoxemia, hemolytic
state or rh-EPO administration were more than five times higher
than in comparabily polycythemic mice whose erythropoieses
were not stimulated before exposure to hypoharia (P-PH, P-PHZ
and P-EPO vs. PC).
Experiment 2. Hypoxia-dependent EPO production in
normocythemic mice at different rates of eiythropoiesis
Erythropoiesis was either stimulated by the s.c. injection of 400
U/kg of rh-EPO on two consecutive days, or depressed by the i.p.
injection of 100 mg/kg of cyclophosphamide. Mice with normal
erythropoiesis were used as controls. Hematocrit level, RBC-59Fe
uptake, pEPO t112 and pEPO concentration were measured in
mice from the three groups three days after treatments. The
hematologic parameters in the three experimental models are
shown in Table 1. It appears evident that the oxygen-carrying
capacity of blood, the pEPO titer and the pEPO half lives were
not significantly different among groups in spite of significant
variations in erythropoiesis. When mice from the three groups
were exposed to hypobaria for six hours three days after treat-
ments to stimulate EPO formation, the derived EPO-PR, as
shown in Figure 2, were 208% of normal in mice with cyclophos-
phamide-induced depression of erythropoiesis and 33% of normal
in those with EPO-induced enhancement of erythropoiesis.
Discussion
Hypoxia-dependent EPO production was estimated in both
polycythemic and normocythemic mouse models previously sub-
Fig. 1. Eiythropoietin-production rate, calculated from average increase in
plasma EPO levels and plasma EPO half-lives, in response to exposure to
hypobaria (0.5 atm, 14 hr) in nomwcythemic mice (NC) and in transfused
polycythemic mice whose eiythrocyte production rates were either not previ-
ously stimulated (PC) or stimulated during a 3-week period by intemiittent
exposure to hypobaria (P-PH), by phenylhydrazine administration (P-PHZ)
or by repeated rh-EPO injections (P-EPO). Symbols are: (•) normocythe-
mic; () polycythemic.
jected to different treatments. It was assumed that the tissue
oxygen supply/demand ratios were similar in both experimental
and control mice of the same model at the time of the hypoxic
induction of EPO production. The assumption was based on
calculation of the oxygen-carrying capacity of blood and body
oxygen consumption. In the presence of equal oxygen supply/
demand ratios any change in hypoxia-dependent EPO formation
could he attributed to influences other than oxygen availability
and/or consumption.
Hypoxia-stimulated EPO production was drastically depressed
in transfused-polycythemic mice. However, this effect of polycy-
themia was no longer observable when mice were erythropoieti-
cally stimulated prior to transfusion, EPO production in such
polycythemic mice being as high as that found in normocythemic
mice. Prior to transfusion, erythropoiesis was stimulated by inter-
mittent exposure to hypobaria, by phenylhydrazine-induced he-
molysis or by repeated rh-EPO injections. Two features were
common to treatments, namely enhanced erythropoiesis and
supranormal plasma EPO titers. One or both, therefore, could be
responsible for the described findings. However, this does not
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Fig. 2. Eiythropoietin-production rates, calculated from average increase in
plasma EPO levels and plasma EPO half-lives, in mice with normal (NE),
depressed (DE) or stimulated (SE) rates of eythropoiesis under hypoxic
conditions (exposure to 50% atmospheric pressure for 4 hrf
Recently, the stimulatory effect of rh-EPO on the EPO gene
expression has been reported [13] which could help to explain the
results obtained.
Hypoxia-dependent EPO production was also estimated in
normocythemic mice during the course of either stimulation or
depression of erythropoiesis induced by administration of rh-EPO
or cyclophosphamide, respectively. Animals so treated showed
normal values of oxygen-carlying capacity of blood, plasma EPO
titer, plasma EPO half-life and body oxygen consumption at the
time of stimulation of EPO formation in spite of significant
alterations in the red cell production rate. Hypoxia-dependent
EPO-PR was inversely related to the level of erythropoiesis
occurring in the animals during exposure to hypobaric hypoxia.
No evidence exists on the nature of the operating mechanism.
However, data suggest that a functional link could exist between
the EPO-responsive cells in the erythropoietic organs and the
EPO-synthesizing cells that could modulate the hypoxia-depen-
dent expression of the EPO gene.
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Table 1. Hematologic parameters, labeled recombinant EPO half-lives and oxygen consumption in mice with normal, depressed or stimulated
erythropoiesis
Hematocrit RBC-59Fe uptake piEPO
mU/miGroup %
Normal 42.3 2.1 26.1 1.8 28.3 5.4 182.8 14.4 3.7 0.4
Depressed 41.6 + 0.8 1.3 0.1 24.6 2.3 198.2 8.6 3.1 0.3
Stimulated 43.4 1.6 34.2 2.0 30.3 3.2 178.6 9.2 3.9 0.6
pEPO t112
mm
02 consumption
liter/kg/hr
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